These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3039178)

  • 21. Isolation and molecular characterization of a poliovirus type 1 mutant that replicates in the spinal cords of mice.
    Jia Q; Ohka S; Iwasaki K; Tohyama K; Nomoto A
    J Virol; 1999 Jul; 73(7):6041-7. PubMed ID: 10364356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic determinants of cell type-specific poliovirus propagation in HEK 293 cells.
    Campbell SA; Lin J; Dobrikova EY; Gromeier M
    J Virol; 2005 May; 79(10):6281-90. PubMed ID: 15858012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype.
    Kawamura N; Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
    J Virol; 1989 Mar; 63(3):1302-9. PubMed ID: 2536835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Reevaluate the effect of G-480 point mutation that determines the neurovirulence of type I vaccine polioviruses].
    Zhang Y; Yan DM; Wang DY; Zhao R; Zhang DY; Ye XF; Zhu SL; An HQ; Xu WB
    Bing Du Xue Bao; 2007 Jan; 23(1):1-8. PubMed ID: 17886713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis.
    Ren RB; Costantini F; Gorgacz EJ; Lee JJ; Racaniello VR
    Cell; 1990 Oct; 63(2):353-62. PubMed ID: 2170026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing.
    La Monica N; Meriam C; Racaniello VR
    J Virol; 1986 Feb; 57(2):515-25. PubMed ID: 3003384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine neurovirulence studies with a chimeric poliovirus: in vivo generation of a mutant base-paired stable attenuated poliovirus.
    Lee C; Young C
    Microb Pathog; 1998 Oct; 25(4):215-25. PubMed ID: 9817825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis.
    Furione M; Guillot S; Otelea D; Balanant J; Candrea A; Crainic R
    Virology; 1993 Sep; 196(1):199-208. PubMed ID: 8102826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular genetic analysis of poliovirus infection].
    Nomoto A
    Yakugaku Zasshi; 1989 Sep; 109(9):622-35. PubMed ID: 2481725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Random selection: a model for poliovirus infection of the central nervous system.
    Georgescu MM; Balanant J; Ozden S; Crainic R
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1819-28. PubMed ID: 9266975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategy for construction of live picornavirus vaccines.
    Nomoto A; Iizuka N; Kohara M; Arita M
    Vaccine; 1988 Apr; 6(2):134-7. PubMed ID: 2838985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis.
    Zhang Y; Wang H; Zhu S; Li Y; Song L; Liu Y; Liu G; Nishimura Y; Chen L; Yan D; Wang D; An H; Shimizu H; Xu A; Xu W
    J Gen Virol; 2010 Feb; 91(Pt 2):421-9. PubMed ID: 19846676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of poliovirus recombinants: accumulation of point mutations provides further advantages.
    Savolainen-Kopra C; Samoilovich E; Kahelin H; Hiekka AK; Hovi T; Roivainen M
    J Gen Virol; 2009 Aug; 90(Pt 8):1859-1868. PubMed ID: 19403755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine.
    Cann AJ; Stanway G; Hughes PJ; Minor PD; Evans DM; Schild GC; Almond JW
    Nucleic Acids Res; 1984 Oct; 12(20):7787-92. PubMed ID: 6093054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mouse neurovirulence of antigenic chimeras (type I/II) of polioviruses].
    Dai C
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):34-8. PubMed ID: 7686824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine.
    Bouchard MJ; Lam DH; Racaniello VR
    J Virol; 1995 Aug; 69(8):4972-8. PubMed ID: 7609067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
    Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
    J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice.
    Tardy-Panit M; Blondel B; Martin A; Tekaia F; Horaud F; Delpeyroux F
    J Virol; 1993 Aug; 67(8):4630-8. PubMed ID: 8392604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine.
    Mento SJ; Weeks-Levy C; Tatem JM; Gorgacz EJ; Waterfield WF
    Dev Biol Stand; 1993; 78():93-9; discussion 99-100. PubMed ID: 8388835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new internal ribosomal entry site 5' boundary is required for poliovirus translation initiation in a mouse system.
    Ishii T; Shiroki K; Hong DH; Aoki T; Ohta Y; Abe S; Hashizume S; Nomoto A
    J Virol; 1998 Mar; 72(3):2398-405. PubMed ID: 9499100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.